Selvita【0RKT】銘柄情報

	リアルタイム株価	レベル2
Forex

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

57.00

買値

0.00

売値

0.00

出来高

0.00

0.00 日の範囲 0.00

57.00 52 週間の範囲 57.00

時価総額

1.318B

前日終値

57.00

始値

時刻

(O)

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

0.00

発行済株式数

23,120,000

配当利回り

PER

-14.31

1 株当たり利益 (EPS)

-3.98

歳入

67.99M

純利益

-92.11M

セクター

Chemicals & Chem Preps, Nec

業界

Chemicals & Chem Preps, Nec

ウェブサイト

ryvu.com

本社

Krakow, Pol

設立

Selvita Sa is listed in the Chemicals & Chem Preps sector of the ロンドン証券取引所 with ticker 0RKT. The last closing price for Selvita was PLN57. Over the last year, Selvita shares have traded in a share price range of PLN 57.00 to PLN 57.00.

Selvita currently has 23,120,000 shares in issue. The market capitalisation of Selvita is PLN1.32 billion. Selvita has a price to earnings ratio (PE ratio) of -14.31.

Ryvu Therapeutics presents clinical and preclinical data on RVU120, RVU305, and novel synthetic lethality programs at the 2024 EORTC-NCI-AACR Symposium

Ryvu Therapeutics presents clinical and preclinical data on RVU120, RVU305, and novel synthetic lethality programs at the 2024 EORTC-NCI-AACR Symposium PR Newswire KRAKOW, Poland, Oct. 23, 2024...

Ryvu Therapeutics to present clinical and preclinical data on RVU120, RVU305, and novel synthetic lethality programs at the 2024 EORTC-NCI-AACR Symposium

Ryvu Therapeutics to present clinical and preclinical data on RVU120, RVU305, and novel synthetic lethality programs at the 2024 EORTC-NCI-AACR Symposium PR Newswire KRAKOW, Poland, Oct. 9, 2024...

Ryvu Therapeutics to present ONCO Prime platform at the 6th Annual RAS-Targeted Drug Development Summit

Ryvu Therapeutics to present ONCO Prime platform at the 6th Annual RAS-Targeted Drug Development Summit PR Newswire KRAKOW, Poland, Sept. 23, 2024 ONCO Prime is a cutting-edge drug discovery...

Ryvu Therapeutics presents clinical and preclinical data on RVU120 at the 2024 European Hematology Association Congress

Ryvu Therapeutics presents clinical and preclinical data on RVU120 at the 2024 European Hematology Association Congress PR Newswire KRAKOW, Poland, June 14, 2024 RVU120 as a single agent showed...

Ryvu Therapeutics to Present Preclinical Data on RVU120 and Synthetic Lethality Programs at the 2024 AACR Annual Meeting

Ryvu Therapeutics to Present Preclinical Data on RVU120 and Synthetic Lethality Programs at the 2024 AACR Annual Meeting PR Newswire KRAKOW, Poland, March 6, 2024 Updated preclinical data will be...

Ryvu Announces Dosing of the First Patient in the RIVER-52 Phase II Study of RVU120 as a Monotherapy for the Treatment of Patients with Relapsed/Refractory AML and HR-MDS

Ryvu Announces Dosing of the First Patient in the RIVER-52 Phase II Study of RVU120 as a Monotherapy for the Treatment of Patients with Relapsed/Refractory AML and HR-MDS PR Newswire KRAKOW...

Ryvu Therapeutics to Present Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Meeting

Ryvu Therapeutics to Present Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Meeting PR Newswire KRAKOW, Poland, Nov. 2, 2023 Updated data from the Phase I trial of RVU120...

Ryvu Therapeutics Reports 2022 Half-Year Financial Results and Provides Corporate Update

Ryvu Therapeutics Reports 2022 Half-Year Financial Results and Provides Corporate Update PR Newswire KRAKOW, Poland, Sept. 28, 2022 KRAKOW, Poland, Sept. 28, 2022 /PRNewswire/ -- Ryvu...

Ryvu Therapeutics Presents Updated Clinical and Preclinical Data on RVU120 at the 2022 European Hematology Association (EHA) Congress

Ryvu Therapeutics Presents Updated Clinical and Preclinical Data on RVU120 at the 2022 European Hematology Association (EHA) Congress PR Newswire KRAKOW, Poland, June 10, 2022 - Clinically...

Ryvu Therapeutics to Present Data from its Oncology Programs at AACR 2022 Annual Meeting

Ryvu Therapeutics to Present Data from its Oncology Programs at AACR 2022 Annual Meeting PR Newswire KRAKOW, Poland, March 8, 2022 KRAKOW, Poland, March 8, 2022 /PRNewswire/ -- Ryvu Therapeutics...

期間 †	始値	高値	安値
1	57	57	57	DE
4	57	57	57	DE
12	57	57	57	DE
26	57	57	57	DE
52	57	57	57	DE
156	57	57	57	DE
260	57	57	57	DE

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
PIPPipehawk Plc	2.00p (48.15%)	440.44k
KBTK3 Business Technology Group Plc	92.50p (48.00%)	9.45k
CMETCapital Metals Plc	2.10p (31.25%)	2.69M
APQApq Global Limited	6.50p (30.00%)	35k
ORCPOracle Power Plc	0.039p (21.88%)	1.25B
GRLGoldstone Resources Limited	1.15p (-26.98%)	4.77M
ARBArgo Blockchain Plc	6.125p (-24.38%)	46.5M
HSSHss Hire Group Plc	5.00p (-16.11%)	580.33k
BBBBigblu Broadband Plc	35.00p (-14.63%)	223.54k
TRYBTribe Technology Plc	1.65p (-13.16%)	256.38k
ORCPOracle Power Plc	0.039p (21.88%)	1.25B
PREMPremier African Minerals Limited	0.056p (2.75%)	357.18M
TRPTower Resources Plc	0.0305p (-1.61%)	239.28M
NTVONativo Resources Plc	0.0025p (0.00%)	231.54M
NTOGNostra Terra Oil And Gas Company Plc	0.0255p (0.00%)	126.93M